World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
50600
World Ranking
10665
National Ranking
1019

Overview

Adrienne M. Flanagan is affiliated with University College London in the United Kingdom. Their research primarily focuses on areas within medicine, biochemistry, genetics, and molecular biology.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broad areas, Adrienne's work spans several subfields, notably:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Rheumatology
  • Genetics

The topics covered by their research involve:

  • Sarcoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Bone Tumor Diagnosis and Treatments
  • Oral and Maxillofacial Pathology
  • Neurofibromatosis and Schwannoma Cases
  • Cancer-related molecular mechanisms research
  • Molecular Biology Techniques and Applications

Adrienne has contributed to the scientific community through multiple recent publications, including:

  • "Sarcoma classification by DNA methylation profiling" (2021), Nature Communications
  • "Osteosarcoma" (2022), Nature Reviews Disease Primers
  • "Signatures of copy number alterations in human cancer" (2022), Nature
  • "Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma" (2020), JAMA Oncology
  • "Origins and impact of extrachromosomal DNA" (2024), Nature

Frequent co-authors frequently collaborating with Adrienne include:

  • Fernanda Amary
  • Roberto Tirabosco
  • Nischalan Pillay
  • Peter Van Loo
  • Maxime Tarabichi

Regarding publication venues, Adrienne's research has appeared repeatedly in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • The Journal of Pathology
  • The Journal of Pathology Clinical Research
  • Diagnostic Histopathology

Best Publications

  • Mutations of the BRAF gene in human cancer

    Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

    Philip J. Stephens;Chris D. Greenman;Beiyuan Fu;Fengtang Yang

  • The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

    S Bamford;E Dawson;S Forbes;J Clements

  • Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.

    W. Bartlett;J. A. Skinner;C. R. Gooding;R. W. J. Carrington

  • IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

    M. Fernanda Amary;Krisztian Bacsi;Francesca Maggiani;Stephen Damato

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Lung cancer: intragenic ERBB2 kinase mutations in tumours.

    Philip Stephens;Chris Hunter;Graham Bignell;Sarah Edkins

  • Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

    Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl

  • Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

    S Vujovic;S Henderson;N Presneau;Edward Odell

  • Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer

    Helen Davies;Chris Hunter;Raffaella Smith;Philip Stephens

  • Mammary and extramammary Paget's disease

    J Lloyd;A M Flanagan

  • Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma

    Hsei-Wei Wang;Matthew W B Trotter;Dimitrios Lagos;Dimitra Bourboulia

  • A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered.

    C.R. Gooding;W. Bartlett;G. Bentley;J.A. Skinner

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

    M Fernanda Amary;Stephen Damato;Dina Halai;Malihe Eskandarpour

  • Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Jose M. C. Tubio;Yilong Li;Young Seok Ju;Inigo Martincorena

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  • A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer

    Philip Stephens;Sarah Edkins;Helen Davies;Christopher Greenman

  • Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

    Sunil R. Lakhani;Sanjiv Manek;Frederique Penault-Llorca;Adrienne Flanagan

Frequent Co-Authors

Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute
Michael R. Stratton
Michael R. Stratton Wellcome Sanger Institute
Sam Behjati
Sam Behjati Wellcome Sanger Institute
Peter Van Loo
Peter Van Loo The Francis Crick Institute
Patrick S. Tarpey
Patrick S. Tarpey Wellcome Sanger Institute
Jon W. Teague
Jon W. Teague Wellcome Sanger Institute
Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
Meredith Yeager
Meredith Yeager Hood College
Ultan McDermott
Ultan McDermott AstraZeneca (United Kingdom)
Piero Picci
Piero Picci University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in health sciences but not sure if medical school is your only path? Many students explore rewarding careers in healthcare through online degrees and specialized certifications.

For those passionate about managing healthcare facilities or leading healthcare teams, an online healthcare management degree provides a flexible path to enter or advance in the dynamic field of health administration.

If you’re a registered nurse looking to move into advanced practice roles, consider asn to np bridge programs. These online options allow you to progress from an associate degree in nursing directly to a nurse practitioner role, often at an accelerated pace.

Those interested in nutrition and wellness can explore a career as a nutritionist or dietitian with online nutrition degree programs, which offer foundational knowledge and practical experience from anywhere.

For senior administration roles or executive positions in healthcare, consider advancing your qualifications through cahme accredited online healthcare administration programs. These programs are recognized for their quality, preparing graduates for leadership across the healthcare system.

Best Scientists Citing Adrienne M. Flanagan

Trending Scientists

Recently Published Articles